Background: Factor C is autocatalytically activated on lipopolysaccharides. Results: The N-terminal Arg of factor C is essential for the autocatalytic activation.
Factor C is a serine protease zymogen involved in lipopolysaccharide-induced innate immune responses in horseshoe crabs, such as hemolymph coagulation, activation of the complement system, and hemocyte exocytosis (1) (2) (3) . Factor C consists of six types of domains, and contains six potential N-linked glycosylation sites ( Fig. 1) (4) . The N-glycosylation plays a pivotal role in its secretion in Drosophila S2 cells (5) . Factor C triggers hemolymph coagulation in response to the stimulation of bacterial lipopolysaccharides: the resulting activated factor C activates factor B, which in turn converts the proclotting enzyme into the clotting enzyme to promote the conversion of coagulogen to coagulin gel (6) . The lipopolysaccharide-induced autocatalytic cleavage occurs within the -Phe 737 -Ile 738 -bond in the C-terminal catalytic domain of factor C, and this peptide bond is also cleaved by chymotrypsin in vitro to trigger the coagulation cascade under sterile conditions (7) . A lipopolysaccharide-binding site is located in the N-terminal Cys-rich domain, and it has been established that a tripeptide sequence (-Arg 36 -Trp 37 -Arg 38 -) in the N-terminal Cys-rich domain is important for lipopolysaccharide recognition (3, 8) .
Proteases involved in proteolytic cascades also reside as latent precursors in the mammalian blood coagulation (9) : the intrinsic pathway begins with the activation of factor XII by the interaction of high molecular weight kininogen and prekallikrein on negatively charged surfaces, and the extrinsic one begins with the activation of factor VII by interaction with tissue factor on lipid surfaces at injured sites. The precise activation mechanism of factor XII or factor VII remains unknown, whereas tissue factor is known to trap one of the conformational states of factor VII, converting its zymogen-like state into an active state (10) . The classical molecular mechanism of the zymogen activation of serine proteases in trypsinogen activation has been established (11) . Trypsinogen is activated by proteolytic cleavage of the -Arg 15 -Ile 16 -bond in chymotrypsinogen numbering, following an insertion of the newly appearing N-terminal Ile 16 into the activation pocket known as the Ile 16 cleft to form a salt bridge between the ␣-amino group of Ile 16 and the side chain of Asp 194 , which triggers conformational changes of the substrate binding site and the oxyanion hole required for catalysis.
Based on the importance of the salt bridge formation at the Ile 16 cleft in zymogen activation, a molecular sexuality model has been proposed for non-proteolytic activation of plasminogen by streptokinase secreted from Streptococcus pyogenes (12) . However, the mechanism of the molecular sexuality model by means of a protein-protein interaction remains unknown, except for non-proteolytic activation of prothrombin by staphylocoagulase (13) (14) (15) . Staphylocoagulase, a non-enzymatic protein secreted by Staphylococcus aureus, binds to prothrombin to form a one to one complex, and inserts its N-terminal portion (Ile 1 -Val 2 -) into the Ile 16 cleft of bound prothrombin to induce a thrombin-like conformation, providing the first structural evidence for the molecular sexuality mechanism of non-proteolytic zymogen activation.
On the other hand, zymogens of intracellular cysteine proteases including caspases-1, -8, and -9 are activated in the signaling platforms of the protein complexes known as inflammasomes, the death including signaling complex, and apoptosomes, respectively (16) . The death including signaling complex recruits pro-caspase-8 to a platform composed of Fas antigen and Fas-associated death domain protein, which leads to the autocatalytic activation of pro-caspase-8 (16, 17) . Likewise, binding of monomers of pro-caspase-9 to an oligomeric platform of apoptosome comprising cytochrome c and Apaf-1 by the N-terminal domain of pro-caspase-9 results in dimerization between the C-terminal catalytic domains to allow the dimer to induce an active state without proteolytic cleavage (18) . One of the two potential active sites in the dimer of procaspase-9 closely resembles the active form, whereas in the second potential active site, expulsion of the active loop disrupts the catalytic machinery (19) . To clarify the molecular mechanism of the autocatalytic activation of factor C on lipopolysaccharides, we prepared several recombinants expressed in a HEK293 mutant cell line lacking N-acetylglucosaminyltransferase I (HEK293S GnTI Ϫ ), 5 which produces recombinants with a restricted and homogeneous N-glycan of Man 5 GlcNAc 2 (20) . Here, we show that the N-terminal Arg and the distance between the N terminus and the lipopolysaccharide-binding site are essential factors for the autocatalytic activation.
EXPERIMENTAL PROCEDURES

Materials-HEK293S GnTI
Ϫ cells were obtained from ATCC. Lipopolysaccharides from Salmonella minnesota R595 (Re) were purchased from List Biological Laboratories Inc. (Campbell, CA). Biotinylation of S. minnesota R595 (Re) lipopolysaccharides was performed using EZ-Link Sulfo-NHS-LC-Biotin (ThermoFisher Scientific). N-tert-ButoxycarbonylVal-Pro-Arg-p-nitroanilide (Boc-Val-Pro-Arg-pNA) was provided from Seikagaku Corporation, Tokyo, Japan. Boc-ValPro-Arg-4-methylcoumaryl-7-amide (MCA) was purchased from Peptide Institute Inc. (Osaka, Japan). A homobifunctional cross-linker dimethyl adipimidate (spacer arm length 8.6 Å) was purchased from Tokyo Chemical Industry Co. Ltd. (Tokyo, Japan). The molecular weights of lipopolysaccharides and Triton X-100 were assumed to be 17,000 and 647, respectively.
Cloning and Mutagenesis-To construct an expression vector of wild-type factor C, plasmid pPSB8/factor C, which contains a DNA encoding the full-length of factor C, was used as a template to amplify DNA of factor C by PCR. The amplified DNA fragment was subcloned into the vector pCA7 (21) . As a secretion signal sequence, a sequence derived from pHLsec (22) or an original signal sequence of factor C was used. Mutations in wild-type factor C were introduced using site-directed mutagenesis by inverse PCR.
Expression of Recombinant Proteins-Recombinant proteins were expressed in HEK293S GnTI
Ϫ cells, and secreted into the culture medium. HEK293S GnTI Ϫ cells were maintained in DMEM supplemented with 1% glutamine, 1% penicillin/streptomycin, and 10% fetal bovine serum at 37°C under 5% CO 2 . DMEM supplemented with wild-type or mutant factor C plasmid (4 g), polyethylenimine (10 g), 1% glutamine, 1% penicillin/streptomycin, and 2% fetal bovine serum was used to transfect HEK293S GnTI Ϫ cells at 80 -90% confluence in a sixwell plate. Culture media were collected 5 days after transfection, and centrifuged at 6,000 ϫ g for 30 min. The resulting supernatant was filtrated, and the concentration of each recombinant protein was determined by ELISA, using a monoclonal antibody 2C12 against factor C (23). Culture media containing recombinant proteins were dialyzed with 10 mM MES-NaOH, pH 6.0, and applied to a CM-Sepharose CL-6B column. After washing with the same buffer, the recombinant proteins were eluted by stepwise elution using 20 -200 mM NaCl in the same buffer. Eluted fractions were subjected to SDS-PAGE, followed by electroblotting to a PVDF membrane. The membrane was stained with Coomassie Brilliant Blue R-250, and the N-terminal sequences of the stained bands were analyzed by Edman degradation (Genostaff, Tokyo, Japan) ( Table 1) .
ELISA-The microtiter plates were coated with the monoclonal antibody 2C12 by incubating overnight at 4°C in 50 mM sodium carbonate, pH 9.6. After washing with 20 mM Tris-HCl, pH 7.5, containing 150 mM NaCl (TBS1), the plates were blocked with 2.5% casein in TBS1, and serial dilutions of the samples were added, incubated at 37°C for 1 h, and washed with TBS1. Polyclonal antibodies against factor C were added and the plates were incubated at 37°C for 1 h. After washing with TBS1, HRP-conjugated goat anti-rabbit IgG antibody (Bio-Rad) was added and the plates were again incubated at 37°C for 1 h. The enzyme activity of HRP was detected with o-phenylenediamine at 492 nm with a microplate reader model 3550 (Bio-Rad) or Multiskan GO (Thermo Fisher Scientific).
Binding Assay to Lipopolysaccharide-immobilized SepharoseSepharose coupled to streptavidin was incubated for 2 h at 4°C in the presence or absence of 10 g of biotinylated lipopolysaccharides in 1.0 ml of TBS1, and Sepharose, obtained by centrifugation at 6,000 ϫ g for 5 min was washed with TBS1. The resulting lipopolysaccharide-immobilized Sepharose or control Sepharose was incubated with culture media containing 4.3 nM recombinant proteins for 1 h at 4°C, and washed three times with TBS1. Sepharose reacted with recombinant proteins was obtained by centrifugation and subjected to Western blotting.
Amidase Activity of Recombinant Proteins Activated by Lipopolysaccharides-Recombinant proteins were incubated in the presence of various concentrations of lipopolysaccharides in 100 mM Tris-HCl, pH 8.0, at 37°C for 20 min. Boc-Val-ProArg-pNA was then added to the solutions at the final concentration of 0.4 mM and incubated at 37°C for 5 min, and acetic acid was added to terminate the reaction. The rate of hydrolysis was calculated from the absorbance at 405 nm. The unit of the amidase activity was defined as micromole of the digested substrate per min. The specific activity was expressed as units per nmol of factor C.
Purification of Recombinants by Dextran Sulfate CL-6B Sepharose Column
Chromatography-Culture media containing recombinants were applied to a dextran sulfate-Sepharose CL-6B column (1.0 ϫ 1.5 cm) prepared previously (24) . The column was washed with 20 mM Tris-HCl, pH 8.0, containing 150 mM NaCl (TBS2), and the recombinant proteins were eluted with the same buffer containing 500 mM NaCl.
Amidase Activity of Recombinant Proteins Activated by Chymotrypsin-Recombinant proteins (17.2 nM) purified by dextran sulfate CL-6B Sepharose column chromatography were incubated with 80 nM ␣-chymotrypsin in TBS2 at 37°C for 30 min, and 0.1 mM tosyl-L-phenylalanine chloromethyl ketone was added to stop the reaction. An aliquot of the recombinants treated with chymotrypsin was incubated with 0.4 mM Boc-ValPro-Arg-pNA in TBS2 containing 1.5 M bovine serum albumin for 5 min at 37°C, and acetic acid was added to terminate the reaction.
Kinetic Analysis-Stock solutions of Boc-Val-Pro-Arg-MCA were prepared in dimethylformamide. Activated recombinant proteins (10 l) were added to a cuvette containing 480 l of TBS2 containing 1.5 M bovine serum albumin thermostatted at 37°C. The initial rate of hydrolysis was measured fluorometrically with excitation at 380 nm and emission at 440 nm after adding the substrate solution. Kinetic parameters were determined by direct linear plotting (25) .
Lipopolysaccharide-binding Assay with a Surface Plasmon Sensor-Biotinylated lipopolysaccharides (2.3 M in 10 mM Hepes-NaOH, pH 7.4, containing 150 mM NaCl) were immobilized on a sensor chip SA of a BIAcore X system (GE Healthcare), according to the manufacturer's specifications. Recombinant proteins were injected at a flow rate of 30 l/min in the running buffer, 10 mM Hepes-NaOH, pH 7.4, containing 150 mM NaCl. The change in the mass concentration on the sensor chip was monitored as a resonance signal by using the program supplied by the manufacturer. Sensorgrams of the interactions obtained by using the various concentrations of recombinant proteins (5-20 nM) were analyzed by the BIAEVALUATION program, version 3.0.
Cross-linking of Recombinant Proteins by Dimethyladipimidate-Recombinant proteins (8.6 nM) purified by dextran sulfate-Sepharose CL-6B chromatography were incubated with 4 mM dimethyl adipimidate in 100 mM triethanolamine-HCl, pH 8.0, at 37°C for 1 h after mixture with various concentrations of lipopolysaccharides and subjected to Western blotting using the monoclonal antibody 2C12 for factor C heavy chain.
Western Blotting-Samples were subjected to SDS-PAGE in 6, 8, or 10% slab gel, and transferred to a PVDF membrane. After blocking with 5% skim milk, the membrane was incubated with the monoclonal antibody 2C12 and then with the secondary antibody (HRP-conjugated goat anti-mouse IgG; Bio-Rad), followed by development with Chemi-Lumi One (Nacalai Tesque, Kyoto, Japan). Precision plus protein standards (BioRad) were used to determine the apparent molecular masses.
RESULTS
Addition of Amino Acids at the N terminus of Factor C Prevents Autocatalytic Activation-A recombinant factor C was expressed in HEK293S GnTI
Ϫ cells; the recombinant had an extra tripeptide of Glu-Thr-Gly derived from the expression vector at the native N terminus (ϩETG-factor C), as confirmed by protein sequencing (Table 1) . Unexpectedly, ϩETG-factor C did not show amidase activity against a chromogenic synthetic substrate, Boc-Val-Pro-Arg-pNA, in the presence of lipopolysaccharides ( Fig. 2A) , suggesting that the extra N-terminal peptide inhibits autocatalytic activation of factor C on lipopolysaccharides. Therefore, the secretion signal sequence of the expression vector was replaced by an original secretion signal sequence of factor C, and the N-terminal sequence of the resulting recombinant factor C (wild-type factor C) was confirmed to be consistent with that of native factor C by protein sequencing (Table 1) . Wild-type factor C exhibited amidase activity against the pNA substrate in the presence of lipopolysaccharides, and the dose-dependent curve of lipopolysaccharides for the autocatalytic activation of wild-type factor C was indistinguishable from that for the autocatalytic activation of native factor C isolated from hemocytes ( Fig. 2A) (26) . The specific amidase activity of wild-type factor C activated under optimum conditions in Fig. 2A was sufficient compared with that previously reported for native factor C (1). Kinetic param- Activation of a Protease Zymogen on Lipopolysaccharide SEPTEMBER 12, 2014 • VOLUME 289 • NUMBER 37
eters of wild-type factor C activated by lipopolysaccharides or chymotrypsin were determined against a fluorescence peptide substrate, Boc-Val-Pro-Arg-MCA. The factor C molecules activated by lipopolysaccharides and chymotrypsin were, respectively, designated ␣-factor C and ␤-factor C. Although K m values of the two active forms are indistinguishable, the k cat value of ␤-factor C was about 40% lower than that of ␣-factor C ( Table 2 ).
The N-terminal Arg Is Essential for Autocatalytic Activation-To examine the effects of addition or deletion of amino acids at the N terminus on the lipopolysaccharide-induced autocatalytic activation, an addition mutant of Ala (ϩA-factor C) or a deletion mutant of Arg-Gly (⌬RG-factor C) was expressed (Table 3 ). In addition, to investigate the significance of the N-terminal Arg, it was replaced by Ala (R1A-factor C), Leu (R1L-factor C), His (R1H-factor C), or Lys (R1K-factor C) ( Table 3) . When these mutants were incubated with lipopolysaccharides, only R1K-factor C, but not the other mutants, exhibited significant amidase activity (Fig. 2B) . However, all mutants could be proteolytically activated by chymotrypsin, and their specific activities were comparable with that of wildtype factor C (Fig. 2C) . These results indicate that the N-terminal Arg of wild-type factor C is essential for lipopolysaccharideinduced autocatalytic activation. When the N-terminal Arg was replaced with Lys, but not when it was replaced with another basic amino acid, His, it showed amidase activity equivalent to that of lipopolysaccharide-induced autocatalytic activation of wild-type factor C, suggesting that the specific interaction of the N-terminal Arg with a target amino acid(s) on factor C is required to trigger autocatalytic activation. In addition, to elucidate the importance of the distance between the N-terminal Arg and the tripartite lipopolysaccharide-binding site (-Arg 36 -Trp 37 -Arg 38 -) for the autocatalytic activation, the addition of mutants Arg (ϩR-factor C) and Arg-Thr-Gly (ϩRTG-factor C) or deletion mutants of Gly (⌬Gly 2 -factor C), Gly-Val (⌬Gly 2 -Val 3 -factor C), and Gly-Val-Asp (⌬Gly 2 -Val 3 -Asp 4 -factor C) were expressed (Table 4) . When these mutants were incubated with lipopolysaccharides, their amidase activities were not detectable, except that ϩR-factor C exhibited 30% relative activity compared with wild-type factor C (Table 4) . These results indicate that the distance between the N-terminal Arg and the lipopolysaccharide-binding site is also an essential factor for autocatalytic activation of factor C. Wild type A Lipopolysaccharide-binding Capacity of Factor C Is Necessary but Not Sufficient for Lipopolysaccharide-induced Autocatalytic Activation-We previously reported that the N-terminal Cys-rich domain of factor C contains the tripartite lipopolysaccharide-binding site, and that a double point mutation in this domain (R36E/R38E-factor C) has no significant lipopolysaccharide-binding activity (8, 27) . The dose-dependent curve of lipopolysaccharides for the autocatalytic activation of R36E/R38E-factor C was examined, and as expected, R36E/R38E-factor C was dysfunctional for lipopolysaccharideinduced autocatalytic activation (Fig. 3A) . To examine whether the N-terminal dysfunctional mutants, including R1H-, R1A-, and R1L-factor C, have a lipopolysaccharide binding capacity, these mutants were incubated with lipopolysaccharide-immobilized Sepharose beads. Unexpectedly, all these N-terminal dysfunctional mutants as well as the functional mutant of R1K-factor C exhibited lipopolysaccharide-binding activity comparable with that of wild-type factor C (Fig. 3B) . To confirm the lipopolysaccharide-binding activity of these mutants quantitatively, the lipopolysaccharide-binding parameters were determined by surface plasmon resonance analysis. These three mutants with dysfunction for lipopolysaccharide-induced autocatalytic activation and the functional mutant R1K-factor C retained an association constant (K a ϭ 0. (Table 5 ). These results indicate that the lipopolysaccharide binding capacity of factor C is necessary but not sufficient for lipopolysaccharide-induced autocatalytic activation.
Factor C Is Autocatalytically Activated with Close Vicinity to be Chemically Cross-linked on Lipopolysaccharides-There was an optimum concentration of lipopolysaccharides for the autocatalytic activation of factor C, namely an optimum molar ratio of factor C to lipopolysaccharides, suggesting that an opportunity to form a complex between at least two molecules of factor C with an adequate molecular orientation on lipopolysaccharides is required to trigger autocatalytic activation ( Fig. 2A ) (26) . To capture the lipopolysaccharide-supported competent complex, wild-type factor C was incubated with the homobifunctional cross-linker dimethyl adipimidate in the presence of lipopolysaccharides, and the resulting cross-linked factor C molecules were detected by Western blotting under reducing conditions, using the monoclonal antibody 2C12 that recognizes the heavy chain of factor C. The cross-linked factor C molecules with molecular masses of 160, 280, and ϳ500 kDa were detected on SDS-PAGE at 5.9 and 59 nM lipopolysaccharides, and cross-linking of factor C molecules was prevented at 590 nM lipopolysaccharides (Fig. 4A) . The dose dependence of lipopolysaccharides for cross-linking of factor C molecules was consistent with that for autocatalytic activation, suggesting that factor C molecules in sufficiently close vicinity leading to autocatalytic activation were specifically cross-linked by dimethyl adipimidate (Fig. 4, B and C) . Based on the finding that the heavy chain had an apparent molecular mass of 80 kDa on SDS-PAGE, the dimer and its multiple species of wild-type factor C seem to be cross-linked (Fig. 4A) . To examine the role of the N-terminal amino acid for cross-linking of factor C molecules, 
TABLE 4
Importance of the distance between the N-terminal Arg residue and the tripartite of the lipopolysaccharide-binding site Relative activities were expressed in percentage terms against the activity of wildtype factor C.
؊3 ؊2 ؊1 1 2 3 4 5
Relative activity 
Activation by lipopolysaccharides
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the N-terminal substitution mutants (R1H-, R1A-, and R1L-factor C) and the functional N-terminal mutant (R1K-factor C) were incubated with dimethyl adipimidate in the presence of lipopolysaccharides. Western blotting showed that the amounts of cross-linked factor C molecules of the dysfunctional N-terminal mutants (R1H-, R1A-, and R1L-factor C) were significantly lower than those of wild-type factor C and the functional N-terminal mutant of R1K-factor C (Fig. 5 ).
An Inhibitory Effect of Triton X-100 on Lipopolysaccharideinduced Autocatalytic Activation-Autocatalytic activation of native factor C on lipopolysaccharides is inhibited in the presence of a synthetic surfactant Triton X-100 (28). To determine whether autocatalytic activation of recombinant factor C on lipopolysaccharides is inhibited by Triton X-100, wild-type factor C was incubated with various concentrations of Triton X-100 in the presence of lipopolysaccharides (59 nM). Autocatalytic activation of wild-type factor C on lipopolysaccharides was inhibited by adding Triton X-100, especially above the critical micelle concentration of Triton X-100 (0.24 mM), suggesting that Triton X-100 is mixed into lipopolysaccharides to form an ineffective platform for the autocatalytic activation of factor C (Fig. 6) .
Effect of Substitution of Acidic Amino Acids in the C-terminal Catalytic Domain-We found an acidic region clustered with three repetitive Asp residues, -Asp 78 -Asp 79 -Asp 80 -, in chymotrypsinogen numbering in the C-terminal catalytic domain of factor C (Fig. 7) , and the corresponding region of trypsinogen or thrombin was exposed to the surface of the molecule (29) . To examine whether the region interacts with the N-terminal Arg 1 , each Asp was replaced by Asn (D814N-factor C, D815N-factor C, and D816N-factor C). When these three mutants were incubated with lipopolysaccharides, they all exhibited a level of amidase activity equivalent to that of the wild-type factor C (Fig. 8) .
DISCUSSION
Wang et al. (5) reported that factor C expressed in Spodoptera frugiperda Sf9 cells, but not expressed in Drosophila S2 cells, exhibits lipopolysaccharide-induced autocatalytic activation; N-glycans of factor C expressed with Sf9 cells contains sialic acid with an ␣(2-6) linkage to galactose more abundantly than that with an ␣(2-3) linkage, whereas N-glycans of factor C expressed in S2 cells is rich in sialic acid with an ␣(2-3) linkage, suggesting that the complexity of N-glycans influences the lipopolysaccharide-induced autocatalytic activation. We reported here that a recombinant factor C with homogeneous N-glycan of Man 5 GlcNAc 2 expressed in HEK293S GnTI Ϫ cells exhibited a level of lipopolysaccharide-induced amidase activity equivalent to that of native factor C isolated from hemocytes ( Fig. 2A) . These results suggest that complex N-glycans have little or no effect on the lipopolysaccharide-induced autocatalytic activation of factor C. Occasionally, recombinant proteins are expressed with extra amino acid sequences at the N-terminal or C-terminal end, such as epitope tags or reluctant sequences derived from an initiating Met and multicloning sites. In this study, ϩETG-factor C with an extra tripeptide and factor C mutants with amino acid additions or deletions at the N terminus were incompetent for the lipopolysaccharide-induced autocatalytic activation, but competent for the chymotrypsin-catalyzed activation (Fig.  2) . Moreover, N-terminal substitution mutants of R1A-, R1L-, and R1H-factor C but not R1K-factor C were also incompetent for the lipopolysaccharide-induced autocatalytic activation (Fig. 2) , indicating that the N-terminal Arg or Lys were essential for autocatalytic activation and its positive charge may interact with an acidic amino acid(s) of the factor C molecule to convert the zymogen into an active form on lipopolysaccharides. The dysfunctional mutants, i.e. R1A-, R1L-, and R1H-factor C, showed lipopolysaccharide-binding activity with an affinity constant equivalent to that of wild-type factor C (Table 5 ), indicating that the lipopolysaccharide-binding activity of factor C is required but not sufficient for lipopolysaccharide-induced autocatalytic activation. Wild-type factor C was chemically cross-linked by dimethyl adipimidate under an optimum concentration of lipopolysaccharides to form a dimer and its multiple factor C molecules, and the amount of cross-linked factor C molecules for the dysfunctional mutants of the N-terminal substitutions was significantly lower than that for wild-type factor C or R1K-factor C (Figs. 4 and 5) .
The surface of lipopolysaccharides appears to function as a platform to induce specific protein-protein interaction between the factor C molecules. Lipopolysaccharides mixed with Triton X-100 did not induce the autocatalytic activation of wild-type factor C as well as native factor C (Fig. 6) , suggesting that lipopolysaccharides mixed with Triton X-100 failed to maintain the platform to induce autocatalytic activation of factor C. The effective autocatalytic activation of factor C requires an optimum ratio of factor C to lipopolysaccharides, and thus increasing the amount of lipopolysaccharides reduces the opportunity for the protein-protein interaction of factor C on the surface of lipopolysaccharides. Interestingly, the k cat value of the recombinant activated by chymotrypsin (␤-factor C) was 40% lower than that activated by lipopolysaccharides (␣-factor C) ( Table 2 ), suggesting that proteolytic cleavage of zymogen factor C by chymotrypsin may occur not only within the -Phe 737 -Ile 738 -bond but also within other site(s), causing the reduction of the kinetic parameter of ␤-factor C.
Here we show that the N-terminal Arg and the distance between the N terminus and the lipopolysaccharide-binding site are essential factors for autocatalytic activation on the surface of lipopolysaccharides. The tripartite lipopolysaccharidebinding site is essential to maintain binding activity with lipopolysaccharide with the association constant (K a ) ϳ10 9 M Ϫ1 (Table  5) . On the other hand, the N-terminal Arg with a constant length from the tripartite lipopolysaccharide-binding site does FIGURE 8. Effects of point mutations at the three-tandem Asp region in the C-terminal catalytic domain on lipopolysaccharide-induced autocatalytic activation. D814N-factor C, D815N-factor C, and D816N-factor C (1.7 nM) were incubated with lipopolysaccharides (59 nM) and assayed with BocVal-Pro-Arg-pNA. The unit of the amidase activity was defined as micromole of the digested substrate per min. The specific activity was expressed as units per nmol of factor C. Data are the mean Ϯ S.D. of three independent replicates. n.s., not significant. not contribute to lipopolysaccharide binding affinity but appears to be essential to induce specific protein-protein interaction between the factor C molecules, leading to autocatalytic activation on lipopolysaccharides. However, the possibility of the molecular sexuality mechanism established by staphylocoagulase is unlikely, because the basic side chains of Arg and Lys, but not the hydrophobic ones, are essential for the lipopolysaccharide-induced autocatalytic activation of factor C (Fig. 2B) . As another possibility, a three-tandem Asp region in the C-terminal catalytic domain may interact with the N-terminal Arg on lipopolysaccharides (Fig. 7) , because the sequence and structure of ␣-thrombin (29) suggest that this region might locate on the surface of the C-terminal catalytic domain. However, autocatalytic activation of substitution mutants D79N-factor C, D78N-factor C, and D80N-factor C was sufficient (Fig. 8) . A triple-point mutation in the region might suggest that this site would interact with the N terminus, but the expression of this mutant was too low to determine its lipopolysaccharide-induced activation. Thus, we need another approach to elucidate the region interacting with the N-terminal Arg. The recombinant factor C with restricted and homogeneous N-glycans produced in this study may be useful for further structure-function studies. Interestingly, tissue-type plasminogen activator, a physiological initiator in fibrinolysis, possesses an intrinsic activity residing in a single-chain form (30) . Renatus et al. (31) reported that the ⑀-amino group of Lys 156 in chymotrypsinogen numbering located in the inside of the C-terminal catalytic domain of the tissue-type plasminogen activator forms a salt bridge with the side group of Asp 194 , promoting an active conformation in the zymogen form. However, the Lys 156 residue in the tissue-type plasminogen activator is replaced by the Gln 156 residue in factor C just as in the case of chymotrypsinogen (Fig.  9) . Therefore, factor C may have no intrinsic proteolytic activity residing in the zymogen form. We propose here that the N-terminal Arg of factor C is essential to induce specific proteinprotein interaction between the factor C molecules in close vicinity with a sufficiently proper orientation on lipopolysaccharides, leading to autocatalytic activation.
